
A zzso zzso zzso zzso dose ranging trial of intravenous zzso zzso zzso factor zzso administration after zzso has been performed in 121 patients with zzso zzso All the doses of zzso used zzso zzso resulted in significant acceleration of zzso recovery, and a zzso effect was apparent zzso zzso zzso At the 20 zzso dose of zzso the median time taken to achieve a zzso count of zzso zzso zzso zzso was reduced from 19 to 13 days zzso zzso zzso and the time to achieve a zzso count zzso zzso zzso zzso on the first of 3 consecutive days, from 26 to 14 days zzso zzso zzso There was a trend to less zzso use in the zzso recipients and the median time in hospital was markedly reduced by 11-15 days zzso zzso zzso There was no toxicity in this study attributable to zzso 

